INSIGHTS ON SOLID DOSE MANUFACTURING

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Barrel-Style vs. Standard Dust Cups vs. Bellows: The Essentials Behind Producing The Highest Quality Tablets Free From Contaminates

  Dust cups and bellows are essential components in tablet manufacturing, utilized to prevent lubricants from contaminating the tablets.

• An Alternative Method Of Drug-Excipient Characterization

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Blister Solutions

  With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

• Solubility Enhancement Via Amorphous Solid Dispersions

  2/27/2025

  Polyvinyl alcohol (PVA) is a versatile polymer platform used to enhance solubility through hot melt extrusion. Explore the role it plays in drug solubility, hydrolysis, and thermal behaviors.

• Tablet Consistency And Punch Length – A Pragmatic Perspective For European Manufacturers

  10/7/2025

  Tablet consistency relies on a balance of formulation, press mechanics, and tooling. Learn why punch length tolerance is often overstated and what other critical factors truly drive quality and uniformity.

• HPAPIS Production: "Where Micrograms Matters"

  4/13/2026

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

• Integration From Formulation Development To Manufacturing, Packaging

  2/27/2025

  Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

• High Potency APIs And The Evolving Demands Of Drug Development

  4/13/2026

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.